Suppr超能文献

老年人氨基糖苷类药物耳毒性筛查

Screening for aminoglycoside auditory toxicity in the old.

作者信息

Cheung R, Clark P, Nicholson P W, Deshmukh A A, O'Neill C J, Dobbs S M, Dobbs R J

机构信息

Section of Medical Statistics, Northwick Park Hospital, Middlesex.

出版信息

Br J Clin Pharmacol. 1990 Jul;30(1):1-11. doi: 10.1111/j.1365-2125.1990.tb03737.x.

Abstract
  1. We have investigated 22 patients receiving gentamicin, mean (s.d.) age 78 (6) years for auditory toxicity, using a standard audiometric technique in a sound-treated room (Study 1). 2. Use of a portable audiometer might allow a larger and more representative proportion of patients treated with aminoglycosides to be screened for ototoxicity. A method for detecting high frequency loss suitable for use in the ward was evaluated in 12 volunteers aged 27 (4) years (Study 2). 3. The error inherent in taking hearing at the start of treatment as a reference point was measured in 16 patients, aged 81 (8) years, prescribed non-ototoxic antibacterials (Study 3). 4. A significant (P = 0.05) reduction in hearing threshold was detected in Study 1, although psychometric tests revealed unchanged or improved ability to co-operate. This occurred only at 4000 Hz, the highest frequency used. The magnitude of this loss, mean 2.5 dB, was similar to that of the improvement in threshold detected (P = 0.0004) early in the course of treatment in Study 3. Thus, underestimation of ototoxicity is likely. 5. If a change of threshold of 10 dB or more is taken arbitrarily to represent a real change in hearing, then there was a significant excess of patients in Study 1 with losses at 4000 Hz only (P = 0.032). The six with such losses at this frequency were older than the rest. However, there was a significant (P less than 0.02) positive correlation between log mean predose serum gentamicin concentration and age. Thus, it remains to be determined whether presbyacusis sensitizes those hair cells which it does not destroy to toxic damage. 6. The cumulative dose of gentamicin (for a course of the duration given) was calculated according to published prescribing aids. There was no systematic reduction in the ratio of the dose recommended by a given aid to the dose prescribed in the six with hearing losses as defined above. 7. In Study 2, thresholds obtained at 6000 Hz in the open ward were, on average, 0.9 dB higher than in the sound treated room, but the effect of venue did not reach statistical significance. In the morning thresholds were marginally, but significantly (P = 0.04), lower than in the afternoon. Precision, as measured by the standard deviation of replicate determination, was independent of test conditions. Using multiple (ten) threshold determinations appeared to improve resolution.(ABSTRACT TRUNCATED AT 400 WORDS)
摘要
  1. 我们使用标准听力测定技术,在隔音室内对22名接受庆大霉素治疗的患者进行了听觉毒性调查,这些患者的平均(标准差)年龄为78(6)岁(研究1)。2. 使用便携式听力计可能会使接受氨基糖苷类药物治疗的患者中有更大比例且更具代表性的人群接受耳毒性筛查。在12名平均年龄27(4)岁的志愿者中评估了一种适用于病房的检测高频听力损失的方法(研究2)。3. 在16名年龄为81(8)岁、开具了非耳毒性抗菌药物的患者中,测量了以治疗开始时的听力作为参考点所固有的误差(研究3)。4. 在研究1中检测到听力阈值有显著(P = 0.05)降低,尽管心理测量测试显示合作能力未变或有所改善。这种情况仅发生在所用的最高频率4000赫兹处。这种听力损失的幅度平均为2.5分贝,与研究3中治疗早期检测到的阈值改善幅度(P = 0.0004)相似。因此,耳毒性可能被低估。5. 如果任意将阈值变化10分贝或更多视为听力的实际变化,那么在研究1中仅在4000赫兹处有听力损失的患者明显过多(P = 0.032)。在该频率有此类听力损失的6名患者年龄比其他人更大。然而,对数平均给药前血清庆大霉素浓度与年龄之间存在显著(P小于0.02)正相关。因此,尚有待确定老年性耳聋是否会使那些未被其破坏的毛细胞对毒性损伤更敏感。6. 根据已发表的用药指南计算庆大霉素的累积剂量(针对给定疗程)。对于上述6名有听力损失的患者,给定指南推荐剂量与所开剂量的比值并没有系统性降低。7. 在研究2中,开放病房中6000赫兹处测得的阈值平均比隔音室中的高0.9分贝,但场所的影响未达到统计学显著性。上午的阈值略低于下午,但差异显著(P = 0.04)。以重复测定的标准差衡量的精密度与测试条件无关。进行多次(十次)阈值测定似乎提高了分辨率。(摘要截取自400字)

相似文献

1
Screening for aminoglycoside auditory toxicity in the old.老年人氨基糖苷类药物耳毒性筛查
Br J Clin Pharmacol. 1990 Jul;30(1):1-11. doi: 10.1111/j.1365-2125.1990.tb03737.x.
2
High-frequency audiometric monitoring for early detection of aminoglycoside ototoxicity.
J Infect Dis. 1992 Jun;165(6):1026-32. doi: 10.1093/infdis/165.6.1026.
9
The incidence of aminoglycoside antibiotic-induced hearing loss.氨基糖苷类抗生素所致听力损失的发生率。
Arch Otolaryngol Head Neck Surg. 1990 Apr;116(4):406-10. doi: 10.1001/archotol.1990.01870040028008.

本文引用的文献

2
Histopathological findings in clinical gentamicin ototoxicity.临床庆大霉素耳毒性的组织病理学发现。
Arch Otolaryngol. 1982 Feb;108(2):65-70. doi: 10.1001/archotol.1982.00790500001001.
7
Effect of heparin on gentamicin concentration in blood.肝素对血液中庆大霉素浓度的影响。
Clin Chim Acta. 1972 Nov;42(1):189-91. doi: 10.1016/0009-8981(72)90394-4.
8
Cochlear damage resulting from kanamycin and furosemide.卡那霉素和速尿导致的耳蜗损伤。
Acta Otolaryngol. 1975 Jul-Aug;80(1-2):86-92. doi: 10.3109/00016487509121305.
9
Why monitor serum levels of gentamicin?为什么要监测庆大霉素的血清水平?
Clin Pharmacokinet. 1978 May-Jun;3(3):202-15. doi: 10.2165/00003088-197803030-00002.
10
A prospective study of gentamicin ototoxicity.庆大霉素耳毒性的前瞻性研究。
Acta Otolaryngol. 1978 Sep-Oct;86(3-4):212-6. doi: 10.3109/00016487809124738.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验